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Biological Consequences of Exposure to Mechanical Vibration: Original Research
Beneficial Effects of Whole Body Vibration
on Brain Functions in Mice and Humans
Ate S. Boerema1,2 , Marelle Heesterbeek2 , Selma A. Boersma1,2,
Regien Schoemaker2, Erik F. J. de Vries1, Marieke J. G. van Heuvelen3,
and Eddy A. Van der Zee2
Abstract
The biological consequences of mechanical whole body vibration (WBV) on the brain are not well documented. The aim of the
current study was to further investigate the effects of a 5-week WBV intervention on brain functions. Mice (C57Bl/6J males, age
15 weeks) were exposed to 30 HzWBV sessions (10 minutes per day, 5 days per week, for a period of 5 weeks; n¼ 10). Controls
received the same intervention without the actual vibration (n¼ 10). Humans (both genders, age ranging from 44-99 years) were
also exposed to daily sessions of 30 Hz WBV (4 minutes per day, 4 days per week, for a period of 5 weeks; n ¼ 18). Controls
received the same protocol using a 1 Hz protocol (n ¼ 16). Positron emission tomography imaging was performed in the mice,
and revealed that glucose uptake was not changed as a consequence of the 5-week WBV intervention. Whole body vibration did,
however, improve motor performance and reduced arousal-induced home cage activity. Cognitive tests in humans revealed a
selective improvement in the Stroop Color-Word test. Taken together, it is concluded that WBV is a safe intervention to
improve brain functioning, although the subtle effects suggest that the protocol is as yet suboptimal.
Keywords
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Introduction
Many vibration studies that were published in the previous
century focused on the detrimental effects of mechanical vibra-
tions in the work environment, for example, when operating
tools (eg, sledgehammer and form machines) or while riding in
a vehicle (eg, truck, helicopter, and tank). The latter vibrations
affect the whole body and for such vibrations, the term whole
body vibration (WBV) was introduced. Reviews of the litera-
ture on work-related vibrations show that exposure to such
levels of vibrations mainly leads to increased health risks of
the musculoskeletal system as well as the peripheral nervous
system.1,2 However, thereafter positive effects of experimen-
tally/therapeutically induced WBV were found, suggesting
that, depending on the settings, WBV is a safe and effective
way to train the musculoskeletal system and to improve phys-
ical performance. For example, increased muscle strength3 and
reduced knee osteoarthritis symptoms4 have been reported. In
addition, WBV improves physiological and health-related
components of physical fitness, such as higher bone density5
and lower blood pressure.6 In elderly patients, WBV improves
mobility, balance, general health status,7,8 as well as body
composition, insulin resistance, and glucose regulation.9
Few studies examined the impact of WBV on cognition and
the brain. In an animal study, rats were exposed to 4 hours of
WBV (30 Hz) per day for 4, 6, or 8 weeks. These rats showed
memory impairment and signs of brain damage.10 Positive
effects of WBV on the brain were found with much shorter
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durations of the WBV sessions. We previously showed in CD1
mice that a 5-week WBV intervention (30 Hz, 5 or 30 minutes
per day for 5 weeks) improved balance beam performance
(sensory motor test) and novel object recognition (memory
test depending on the cortex) in a dose-dependent manner.11
In C57Bl/6J mice, we showed that a 5-week WBV interven-
tion resulted in increased activity of the cholinergic system in
the somatosensory cortex and amygdala,12 brain regions
innervated by the cholinergic cells of the nucleus basalis in
the forebrain. Preliminary studies showed that the expression
of the immediate early gene c-fos, indicative for enhanced
neuronal activity, was enhanced by WBV.13 Increased neu-
ronal activity is directly associated with acute increased glu-
cose metabolism,14 whereas a decrease in basal levels of
glucose metabolism is typically interpreted as indicative for
brain pathology, and for instance considered an early biomar-
ker for Alzheimer disease.15,16 No data are available about
possible changes in glucose metabolism in the brain after
WBV stimulation.
18F-fluorodeoxyglucose (18F-FDG) positron emission tomo-
graphy (PET) is a sensitive method for longitudinal, in vivo
measurement of glucose metabolism in tissues of humans and
also small rodents. Contrary to traditional methods such as
indirect calorimetry and doubly labelled water, it has the
advantage that it can measure tissue specific glucose metabo-
lism in living animals and humans. 18F-fluorodeoxyglucose
PET small animal imaging is routinely used in our group to
evaluate the effects of interventions on brain metabolism17-19
and is sensitive enough to detect small physiological differ-
ences, such as time-of day differences in brain and heart glu-
cose uptake in mice.20 To further examine whether WBV is
safe for the brain, we herein studied baseline brain glucose
uptake with 18F-FDG PET before and after a 5-week WBV
intervention in C57Bl/6J mice.
In human studies, mixed effects were found for cognition
with some evidence toward a detrimental effect, but without
indications of a dose–response relationship. Two studies found
some positive acute effects of WBV. In a study of Ishimatsu
et al (2016) lower reaction times during WBV versus control
were found on a sustained attention go no-go task.21 However,
these lower reaction times went together with more errors sug-
gesting a speed-accuracy trade-off. Zamanian and coworkers
found improved performance on a divided attention (choice
reaction time) task but not on a selective attention task, which
holds true for 3 different vibration magnitudes without a spe-
cific magnitude effect.22 One other study examined a dose–
response relation in which the magnitudes of the vibrations
were varied (1.0, 1.6, and 2.5 m/s2 rms), but found no differ-
ences on a short-term memory task.23 This is to a large extent in
agreement with the findings of Sherwood and Griffin (1990).24
In a few studies, short-term effects of WBV were examined.
The WBV vibration with limited durations (2-10 minutes)
appeared to improve attention/inhibition measured immedi-
ately after the WBV, but effect-sizes were generally small,25
except for young adults with attention deficit hyperactivity
disorder who achieved larger improvements.26-28 In this study,
we performed a pilot study with a 5-week WBV intervention in
older adults aged >40 years.
Taken together, this study set out to examine the impact of a
5-week WBV intervention on brain functioning in mice and
humans. Specific aims of the study were (1) to examine glucose
uptake in the brain, (2) to test whether WBV reduces arousal-
induced activity (both mouse studies), and (3) to test executive
functioning and memory in humans using a WBV intervention
that is adapted from the 5-week WBV intervention used in mice.
Materials and Methods
Animals and Housing
Twenty young male C57Bl/6J (age 15 weeks at the start of the
experiments; Charles River, France) mice were used. The mice
were divided in 2 groups, balanced for body mass: a WBV
group (n ¼ 10) that underwent a 5-week WBV protocol and
a control group (sham stimulated mice, termed pseudoWBV
[pWBV]; n ¼ 10) that received pseudo stimulation. Mice were
kept on a 12:12 light/dark cycle at a temperature of 21C +
2C. Mice were sedentary housed. Food, RMH-B 2181 (AB
diets BV, Woerden, the Netherlands), and water were available
ad libitum throughout the experiment.
Whole Body Vibration Protocol for Mice
The WBV protocol for mice was adapted from our previous
studies in CD1 and C57Bl/6J mice11,29 and was described in
more detail by Keijser and colleagues.11 The WBV setup (see
Figure 1A) consisted of an oscillator (LEVELL R.C. Oscillator
Type TG200DMP) and power amplifier (V406 Shaker Power
Amplifier). A box (44.5 (L)  28 (W)  16 (H) cm) was
attached to the oscillator which contained 12 removable com-
partments for individual mice (6.5 (L)  ¼ 7.5 (W)  20 (H)
cm). During the stimulation procedure, mice in the WBV group
were placed in the compartments and subjected to low intensity
sinusoidal vibrations with a frequency of 30 Hz, as described
previously by Keijser and co-workers11 for 10 minutes (ampli-
tude 0.0537 mm; g-force (peak) 0.098 g). Mice in the pseudo
stimulated pWBV group served as controls and were placed in
the compartments at the same schedule and for the same
amount of time, but the oscillator was not turned on. Treatment
sessions were performed during the light-phase on weekdays.
To prevent putative time of day and anticipatory effects, the
timing of treatment sessions varied every day and was ran-
domly distributed over the light-phase. A rotation schedule was
used to place mice at varying locations in the removable com-
partments, correcting for location dependent small variations in
the stimulation intensity of the device.11 Mice were subjected
to the WBV or pWBV protocol for 37 days, containing in total
27 stimulation days.
Motor Performance (Balance Beam)
The balance beam is a sensorimotor integration test, which
focuses on hind limb functioning.30 In our lab, this test has
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been proven to be sensitive to the effects of disease pheno-
type,31 exercise32 and also WBV stimulation,11 in different
mouse strains. This test was, therefore, included as a control
for the effectiveness of the WBV protocol in this experiment.
The balance beam apparatus consisted of a 5 mm wide and
100 cm long aluminum beam. The beam was elevated 50 cm
above the floor. One end of the beam contained a platform on
which the home cage of the test mouse was placed, as a safe
exit for the mice. The top of the cage was in level with the end
of the beam. Prior to the first test session mice were trained to
cross the beam in the right direction by placing them consecu-
tively 5, 10, and 40 cm from the home-cage on the beam and
guiding them toward the home-cage if necessary. A test session
consisted of 3 consecutive trials crossing the full 100 cm length
of the beam. All trials were recorded. The video files were
scored by a previously trained observer. The observer was
blinded for the trial, experimental condition, and time-point
of the movies by randomization of the video files. The average
crossing time of 3 correct trials for each mouse was used in the
analysis. The balance beam test was performed twice; in the
week prior to the start of the WBV protocol, and at the end of
the WBV protocol, and on the day following the day of the last
treatment session.
Arousal-Induced Home Cage Activity Measurements
Besides improvements in cognition and motor performance,
observations in previous experiments indicated that during
WBV mice quietly explored the box, sometimes displayed
rearing (against the wall of the box) or grooming, or lied down.
Pseudo whole body vibration mice typically revealed more
aroused behavior, continuing exploring the box during the
entire pWBV session. These observations suggested that WBV
reduces arousal-induced activity. We, therefore, also monitored
the acute effect of WBV and pWBV in the C57Bl/6J mice. At 3
different time-points, the acute effect of the WBV/pWBV treat-
ment on arousal was measured on day 1, after the first treatment
session, on day 17, and after the last treatment on day 37. In the
minute directly following the treatment session, the mice were
transferred to their own home-cages, without the wire-mesh lid
on. The home cages were subsequently video recorded from
above, for 5 minutes, with a camera using a recording speed of
25 frames/second. The mice were individually tracked, using
the center point of the body as the marker. Mice were tracked
using the grey scaling method and a sampling frequency of 12.5
frames/second with the Ethovision XT 11.5 (Noldus, Wagenin-
gen, the Netherlands) software package. The total distance
moved in centimeter was extracted as a measure for arousal-
induced home cage activity.
Brain Glucose Uptake in Mice
Brain glucose uptake was measured by means of 18F-FDG PET
scans in the week before and after the treatment protocol. The
scan protocol was designed to optimize the detection of 18F-
FDG brain uptake and adapted from Fueger and colleagues.32
Mice were food deprived 6 hours prior to the scan. Mice were
than briefly anaesthetized for 2 to 3 minutes with isoflurane in
medical air (induction 5%, maintenance 1.5%). During this
period, 18F-FDG (5.64 MBq; standard deviation [SD] 0.70) was
administered intravenous via penile vein injection. During the
60-minute tracer uptake period, the mice were housed in their
own home cage in a quiet environment, at 30C+ 1C, within
the thermoneutral33 ambient temperature zone for mice. Just
before the PET scan, mice were anaesthetized again with iso-
flurane in medical air (induction 5%, maintenance 1.5%) and 4
mice per scan were placed, in prone position, on heating-pads,
in the dedicated small animal PET camera (Focus 220, Siemens
Medical Solutions, Malvern, Pennsylvania). A 10-minute static
scan was acquired, starting 60 minutes after tracer injection. A
transmission scan was obtained for attenuation and scatter cor-
rection, using a 57Co point source.
Positron emission tomography scans were iteratively
reconstructed (OSEM2D, 4 iterations, and 16 subsets) into a
Figure 1. A, Set-up of the mouse platform: a box (2), (length: 44.5 cm, width: 28 cm; height: 16 cm) is connected to a vibrator (1). Mice are
placed in separate compartments (3) to avoid social interactions (eg, fights between males); 4 ¼ amplifier; 5¼ oscillator. B, Set-up of the human
platform, with a chair mounted on a vibration platform suitable for wheel chairs.
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single frame after being normalized and corrected for attenua-
tion and decay of radioactivity. Images with a 512  512  95
matrix, a pixel width of 0.475 mm, and a slice thickness of
0.796 mm were obtained. Individual animal head regions,
containing the brain, were cropped from the image using
AMIDE 1.05 Software.34 The images were resliced into cubic
voxels (0.2 mm) and converted into %injected dose per gram
(%ID/g) ¼ (tissue activity concentration [MBq/g]/injected
dose [MBq])  100, assuming a tissue density of 1 g/mL. The
18F-fluorodeoxyglucose uptake was not corrected for blood
glucose levels .17,35
Using VINCI 4.72 software (Max Planck Institute for Meta-
bolism Research, Germany) the images were first automati-
cally co-registered to each other and an average image based
on all individual images was constructed. The average image
was manually aligned to a C57Bl/6J magnetic resonance ima-
ging (MRI) brain atlas.36 Subsequently, the original individual
images were then co-registered to the average image aligned
with the MRI atlas. An atlas-based region of interest (ROI) was
created for the whole brain, excluding the Bulbus olfactorius
and the caudal part of the brainstem, because these regions are
most affected by partial volume effects. The %ID/g values
were extracted for this ROI in all mice and analyzed.
Whole Body Vibration Protocol for Humans
Design. In this pilot study, a double-blind randomized clinical
trial was performed with an experimental group receiving an
experimental WBV intervention and a control group receiving a
sham intervention. Randomization was done by an independent
person using random numbers and with a 1:1 allocation ratio.
Participants. Healthy participants were recruited among person-
nel, volunteers, and partners of inhabitants of 2 nursing homes
in the North of the Netherlands. Inclusion criterion was age >40
years. Exclusion criteria were wheelchair bound, serious car-
diovascular problems, cerebral trauma, epilepsy, rapidly pro-
gressive or terminal disease, degenerative neurological illness,
a history of alcoholism or drugs abuse, depression, severe
visual or auditory problems, and problems with the Dutch lan-
guage. A total of 34 participants completed the study. The
experimental group included 18 participants (mean age 65.8
years with range 42-99 years; 61.1% females; mean Mini-
Mental State Examination (MMSE) score 29.1 with range
27-30), the control group included 16 participants (mean age
66.0 years with range 45-90 years; 50.0% females; mean
MMSE score 28.1 with range 27-30).
Interventions. A vibration platform with chair, developed by Pac-
tive Motion (type Rolstoelpod), was used (see Figure 1B). The
platform generated vertical vibrations with a frequency of 30 Hz
and amplitude of 0.5 to 1 mm for the experimental group and 1
Hz and 0.5 to 1 mm for the control group. Resulting in g-force
(peak) of 0.9 to 1.8 g for the experimental group, and 0.002 g
(peak) for the control group. The participants underwent the
vibrations while sitting on the chair with their back against the
back of the chair, their arms on the rests, and their feet (without
shoes) on the surface of the platform. In both groups, vibration
sessions were performed within 4 minutes per session, 4 sessions
per week, and during 5 weeks, containing in total 20 stimulation
days. The sessions were guided individually by well-trained
students in human movement sciences.
Procedures. Baseline assessments were performed 3 days before
the first WBV session. The WBV sessions were given in an
exercise room. One day after the last WBV session, the post-
intervention assessments were performed. The assessments
were performed in a quiet room. Baseline and postintervention
were guided by the same assessor. Once a week, the partici-
pants rated the comfort of the WBV session on a scale from
1 (very unpleasant) to 10 (very pleasant).
Measures. Cognitive function was measured with 3 tests: the
Stroop test, Digit Memory Span forward/backward, and the
Trailmaking Test (TMT).
The Stroop test was used to measure selective attention and
inhibition.37 The Stroop test consisted of 3 parts. In the Word
test, the participants had to name 100 names of colors (red,
blue, green, or yellow) printed in black as fast as possible.
In the Color-Block test, they had to name the color of 100
squares (red, blue, green, or yellow). In the Color-Word test,
the participant had to name the ink color of 100 color names
(red, blue, green, or yellow) printed in a color other than the
name (eg, the word red was printed in yellow ink). For each
task, the time to complete the task was recorded. The interfer-
ence score was calculated by subtracting the score on the
Color-Block test from the score on the Color-Word test.
The Digit Span Forward test was used to measure verbal
short-term memory.38 During this test, the participant was
asked to repeat series of verbally presented digits. The number
of digits increased by 1 digit every 3 trials. The test was
stopped when 2 or more errors were made in a series with the
same length. The score was the number of series correctly
repeated. The Digit Span Backward test was used to measure
verbal working memory.38 The test was similar to the Digit
Span Forward test with 1 exception and the participant had to
repeat the series in the reversed order.
The TMT was used to measure cognitive flexibility. Besides
cognitive flexibility, the TMT test was suggested to measure
visuomotor speed and attention.39 The TMT consisted of
2 parts. In part A, the participant had to draw a line between
encircled numbers in the ascending order (1-25). In part B, the
participant had to draw a line alternating between circles with
numbers (1-13) and letters (A-L) in the ascending order (1-A-2-
B-3-C). For both parts, the time needed to complete the task
was recorded. In addition, the interference score was calculated
by subtracting the score on part A from the score on part B.
Statistical Analyses of Mouse and Human Data
Animal data were processed and analyzed for statistical differ-
ences using Microsoft Excel (version 2016) and Systat
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Sigmaplot (version 12.5). Data were checked for normality
(Shapiro-Wilk test) and equal variance (Levene median test)
and subsequently analyzed with 2-Way-Repeated Measures
analysis of variance. If a significant main effect or interaction
was present, pairwise multiple comparisons using the Holm-
Sidak method were performed. Data were reported as average
values with the standard error of the mean (SEM), unless stated
otherwise. Human data were analyzed using SPSS version 23.
Differences between the experimental and control group in
perceived comfort were examined with a nonparametric
Mann-Whitney U test. Differences in intervention effects were
investigated with analyses of covariance with the pretest to
post-test gain scores on the cognitive tests as dependent vari-
ables, group (experimental and control) as between-participant
factor and age as covariate. Partial Z2 effect sizes were calcu-
lated. Benchmarks of 0.01, 0.06, and 0.14 were used to indi-
cate, respectively, small, moderate, and strong effect sizes. The
cut-off value used for statistical significance was P < .05 for
both animal and human data.
Ethics of Mouse and Human Experiments
The animal experiments were approved by the Institutional
Animal Care and Use Committee of the University of Gronin-
gen under license number: DEC6321C. The human study was
approved by the Medical Ethical Committee of the University
Medical Center Groningen and registered in the Dutch trial
register (NTR4512). The study was performed in accordance
with the Declaration of Helsinki. All participants signed
informed consent. The GPS location of the studies was latitude
53 130 9,0100 N; longitude 6 340 0,0100 E.
Results
Mouse Study
Body mass. Mean body masses at the start of the experiment on
the day of the PET scan were 25.3 g (SEM 0.50) for the WBV
mice and 25.3 g (SEM 0.46) for the pWBV mice. At the end of
the experiment during the final PET scan, WBV mice weighed
27.0 g (SEM 0.53) and PWBV weighed 26.8 g (SEM 0.49).
There was a significant increase in body mass over time in both
groups (F(1,18) ¼ 34.8; P < .001), but there were no differences
between the experimental groups before (t ¼ 5.082 10015;
P ¼ 1), or after treatment (t ¼ 0.286; P ¼ .78).
Balance beam test. The comparison between the pretest and
post-test values of the time needed to cross the balance beam
revealed that mice in both groups increased their performance
over time (Figure 2). The WBV mice increased performance by
21.3% and the pWBV mice by 11.9%. This resulted in a sig-
nificant main effect of time in the statistical analysis (F(1,18) ¼
10.974; P ¼ .004), but not of treatment (F(1,18) ¼ 0.870; P ¼
.363). However, post-hoc analysis revealed that only the WBV
stimulated mice showed a statistically significant increase in
performance. On average, the WBV mice crossed in 21.00
seconds (SEM 1.36) before treatment and in 16.5 seconds
(SEM 0.98) post-treatment (t ¼ 2.989; P ¼ .008). The pWBV
mice took on average 21.26 seconds (SEM 1.32) to cross the
beam pretreatment, and 18.73 seconds (SEM 1.66) posttreat-
ment (t ¼ 1.695; P ¼ .107).
Arousal-induced home cage activity. The activity measures
revealed an acute suppressing effect on home cage activity
immediately following the WBV treatment. Figure 3A shows
the difference in the distance that the mice moved within their
home cages during the 5 minutes immediately following WBV
or pWBV stimulation. The average of all 3 measurements (day
1, 17, and 37) were included in the group average. The WBV
mice moved on average 211 cm (SEM 10) and the pWBV
moved 250 cm (SEM 13) during the first 60 seconds following
treatment. This decreased over the course of 5 minutes to 172
cm (SEM 9) for the WBV group and 184 cm (SEM 9) for the
pWBV group. There was a significant main effect of time on
the distance moved (F(1,18) ¼ 55.931; P < .001). Post-hoc anal-
ysis on the group level revealed that there was only a statisti-
cally significant difference between WBV and pWBV mice
during the first 60 second interval (t ¼ 2.553, P ¼ .018). This
was also reflected in the effect sizes over the analysis time-
frame (Figure 3B). The effect size (Cohens d) decreased from
1.07 in the first 1-minute bin to 0.43 in the final bin. We,
therefore, only used the first 1-minute bin in the analysis of
home cage activity over the treatment time (Figure 3C). In the
first minute after treatment, the WBV mice always showed less
arousal-induced home cage activity than the pWBV group on
all 3 time points during the intervention protocol, as reflected
by a significant main effect of treatment (F(1,18) ¼ 5.466; P <
.031). This effect increased during the intervention. Post-hoc
analysis revealed that there was a statistically significant effect
(t ¼ 2.247; P ¼ .029) after the final treatment on day 37. The
Figure 2. Balance beam crossing time of the WBV and pWBV mice
(n ¼ 10 each), before (black bars) and after (white bars) the 5 week
WBV protocol. Only the WBV animals increased their performance
statistically significant (*2-way-RM-ANOVA: post-hoc Holm-Sidak for
WBV: t ¼ 2.989; P ¼ .008). pWBV denotes pseudo whole body vibra-
tion; RM-ANOVA, repeated measures analysis of variance; WBV,
whole body vibration.
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WBV mice moved on average 211 cm (SEM 15) and the
pWBV mice moved 267 cm (SEM 29) on this day.
Brain glucose metabolism. The 18F-fluorodeoxyglucose PET ima-
ging revealed no substantial differences between the WBV and
pWBV groups before and after the intervention protocol
(Figure 4). The 18F-FDG uptake for the WBV mice was
3.77%ID/g (SEM 0.14) pretreament and 3.87%ID/g (SEM
0.10) posttreatment. The uptake for the pWBV group was
3.65%ID/g (SEM 0.13) pretreatment and 4.04%ID/g (SEM
0.16) posttreatment. There were no significant main effects
(effect of treatment: F(1,18) 0.0255; P ¼ .875, effect of time:
F(1,18) 4.317;P¼ .052), therefore not allowing post-hoc analysis.
Human Study
Perceived comfort was 7.0 (SEM 1.5) for the experimental
group and 6.9 (SEM 1.6) for the control group (P > .05).
Table 1 shows the cognitive test results for both groups at
baseline and for the gain scores. Positive values on the gain
scores indicate an improvement in test score from baseline to
post-test. For all tests except the Trailmaking A test, the experi-
mental group improved more than the control group. However,
the differences were generally small with only a statistically
significant effect for the Stroop Color-Word test with a nearly
strong effect size (Figure 5). For the Stroop interference score,
a statistically moderate nonsignificant effect was found.
Discussion
In summary, PET imaging revealed that glucose uptake was not
changed as a consequence of a 5-week WBV intervention. The
WBV did, however, improve motor performance and reduced
arousal-induced activity in mice. Cognitive tests in humans
revealed a selective improvement in the Stroop Color-Word test.
Taken together, it is concluded that our WBV intervention is a
safe intervention that can improve at least some aspects of brain
functioning. A limitation of the cognitive test in the human
study, however, might be that we did not control for variables
such as dietary supplements, caffeine intake, or sleep quality.
Other factors influencing the direct comparison between mice
and humans are based on the inherent differences between the
species. Mice received WBV while standing on 4 legs, sitting or
lying down, or a combination of these, whereas our 2-legged
human participants were seated. Also the number of WBV ses-
sions and the duration of the WBV session (respectively, 37 and
10 minutes in mice, and 27 and 4 minutes in humans) were not
similar. The reason for the lower number of WBV sessions in
humans was to ensure high adherence rates and to prevent to ask
too much from our participants and supervisors (in case of the
older participants). The shorter duration of the WBV session was
based on pilot studies in which it was found that WBV sessions
longer than 4 minutes were perceived as too long for the older
participants as used in this study. Nonetheless, we found positive
effects of WBV in both mice and humans.
Figure 3. (A) Distance moved per 60 seconds bin, averaged per animal for days 1, 18, and 37. The corresponding effect sizes (Cohen d) are
shown in (B). (Error bars are SEM; *two-way-RM-ANOVA: post-hoc Holm-Sidak for WBV vs pWBV: t ¼ 2.553; P ¼ .018). (C) Distance moved
when returned to the home cage in the first minute after the first WBV session (day 1), after 2.5 weeks (day 17), and at the end of the WBV
intervention (day 37) (Error bars are SEM; *2-way-RM-ANOVA: post-hoc Holm-Sidak for WBV vs pWBV: t ¼ 2.553; P¼ .018). pWBV denotes
pseudo whole body vibration; RM-ANOVA, repeated measures analysis of variance; SEM, standard error of the mean; WBV, whole body
vibration.
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Figure 4.Overview of the average brain 18F-FDG uptake in %ID/g (bar-chart) pre- and post-treatment for the WBV and pWBV mice. The top
right panel shows an overlay of the 18F-FDG PET data with the C57Bl/6 J mouse MRI brain atlas19 in the horizontal, coronal, and sagittal plane.
The light colored region indicates the brain regions included in the ROI. The darker colored regions (bulbus, caudal part of the brain-stem) are
excluded from the ROI. The bottom 4 panels show the average uptake for the WBV and pWBV mice (n ¼ 10 each) before and after the WBV
intervention. 18F-FDG denotes 18F-fluorodeoxyglucose; %ID/g, %Injected Dose per gram; MRI, magnetic resonance imaging; PET, positron
emission tomography; pWBV, pseudo whole body vibration; ROI, region of interest; WBV, whole body vibration.
Table 1. Means and Standard Deviations (SDs) of Baseline and Gain Scores (From Baseline to Post-test) for the Cognitive Test Scores of the
Experimental (WBV) and the Control (pWBV) Group and the Results of the Analyses of Covariance.
Baseline Gain From Baseline to Post-testa






N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) Fc P ESd
Stroop word (s) 18 50.8 (13.5) 16 51.1 (12.4) 18 0.25 (8.7) 16 0.25 (6.3) 0.034 .855 0.001
Stroop color-block (s) 18 66.4 (21.8) 16 67.5 (19.8) 18 9.04 (12.7) 16 6.63 (10.8) 0.564 .458 0.018
Stroop color-word (s) 17 115.9 (48.9) 15 120.8 (48.8) 17 27.4 (23.4) 15 11.6 (20.2) 4.587 .041 0.137
Stroop interference (CW-C) (s) 17 50.4 (32.8) 15 54.8 (31.6) 17 19.0 (22.3) 15 7.20 (18.2) 2.604 .117 0.082
Trailmaking A (s) 18 46.6 (27.9) 16 51.9 (41.0) 18 2.63 (12.6) 16 3.18 (16.0) 0.011 .915 0.000
Trailmaking B (s) 17 125.7 (104.7) 14 125.3 (89.8) 17 19.3 (31.4) 14 8.89 (23.0) 0.847 .365 0.029
Trailmaking B-A (s) 17 79.7 (81.8) 14 83.82 (70.6) 17 17.8 (35.8) 14 8.97 (20.2) 0.488 .491 0.017
Digit span forward (#digits) 18 11. 9 (3.8) 15 10.9 (2.7) 18 0.89 (2.2) 15 0.40 (2.2) 0.381 .542 0.013
Digit span backward (#digits) 18 7. 8 (2.6) 15 7.5 (3.1) 18 0.22 (1.9) 15 0.13 (2.9) 0.122 .729 0.004
Abbreviations: SD, standard deviation; pWBV, pseudo whole body vibration; WBV, whole body vibration.
aPositive values correspond to improvement from baseline to post-test and negative values to decrease in test performance.
bDifference between experimental and control group with age as the covariate.
cdf ¼ 1,28-31.
dPartial Z2 effect size.
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The improvement in motor performance in the C57Bl/6J is
in line with what we previously showed for the CD1 mice.11
This corroborates the notion that WBV is known to improve
neuromuscular performance.40 The pWBV animals did
improve as well, which could be attributed to a learning
effect. Higher physical activity immediately after pWBV
compared to WBV suggests that WBV reduces experimen-
tally induced behavioral arousal. The arousal-reducing effect
gradually increased in magnitude over the course of the
experiment. The effect decreased within minutes after a ses-
sion, as can be observed in Figure 3A, indicating a rather
acute effect of WBV. If such an arousal-reducing effect also
occurs in humans, it could contribute to the observed acute
effects of WBV on attention.25 Of note, the results also make
clear that the 5-week WBV protocol by itself does not induce
behavioral arousal in mice.
The cholinergic projection from the nucleus basalis in the
forebrain to the amygdala might be involved in this arousal-
reducing effect, as it is known that this projection responds to
sensory input.41 These cholinergic cells appear to be ideally
located within the basal forebrain for evaluating sensory sti-
muli for their level of significance, via inputs from the mid-
brain and limbic system, and to modulate intrinsic cortical
responsiveness appropriately in order to attend to sensory
stimuli (see, for review, Wenk, 1997). Electrophysiological
evidence has implicated cholinergic cells of the nucleus basalis
in the control of attentional processes, as well as a role in the
control and maintenance of arousal. We previously demon-
strated that a 5-week WBV intervention results in an increased
activity of the cholinergic projection of the nucleus basalis to
the amygdala and neocortex.12 Activation of the cholinergic
system may, therefore, play a key role in the effects of WBV
we found in mice and humans. Whole body vibration can be
viewed as a form of passive exercise, which would be in line
with observations that voluntary exercise can reduce arousal-
induced activity and dampens anxiety-related behavior.42,43
Even restricted exposure to voluntary exercise (a running
wheel for 2 hours per day for 12 days) resulted in reduced
anxiety behavior in mice.44 Also in humans, exercise can alle-
viate anxiety.45
To the best of our knowledge, this is the first 18F-FDG PET
imaging study in the brain, related to WBV. The 18F-FDG PET
data in our study did not reveal any significant difference in
brain uptake ratio due to WBV. There was a small but not
significant increase in the pWBV group posttreatment. Other
(unpublished) data from our group typically indicate a much
stronger brain glucose uptake over time if animals are more
aroused during the tracer uptake period. The effects of brain
glucose uptake are very sensitive to peripheral glucose meta-
bolism.32 As such it may well be that the absence of the
increase in brain glucose uptake is associated with the arousal
decreasing effect of the WBV protocol observed in this study.
In humans, brain glucose metabolism was studied in relation
to high intensity and aerobic exercise. An acute global
decrease in brain metabolism has been found immediately
after exercise.46 Long-term chronic exercise interventions
show more mixed patterns in glucose uptake increases, or
decreases which seem very brain region specific. One study
found an increase in glucose uptake in parietal-temporal
and caudate regions after 12-week high intensity training.47
A 3-month walking intervention in older women on the other
hand showed differences in glucose uptake in varying brain
regions between the control and the treated group, but no
global differences in glucose uptake were observed.48 Our
results in mice after WBV stimulation are in line with these
mixed findings in humans and indicate no major beneficial,
but certainly also no detrimental effects of WBV in mice on
baseline global brain glucose metabolism. It may well be that
there are brain region-specific effects of the WBV stimulation
in mice, but the detection of such effects in mice is hampered
by the spatial resolution of PET.
The aim of the human part of this study was to explore the
effects of a 5-week WBV intervention protocol in a sample of
older adults without cognitive impairments. Our results showed
that the experimental WBV with 30 Hz versus pWBV with 1
Hz improved the performance on the Stroop Color-Word test
but not on other conditions of the Stroop test. In addition, no
beneficial or detrimental effects were found for the TMT test
and the Digit Span tests. These results are partly in line with
prior research on the short-term effects on WBV in younger
populations. The Stroop interference scores appeared to be
better after WBV versus resting condition25,26,28 and without
an improvement in the Stroop Color-Block test score.25,28 Sim-
ilar to the current study, Regterschot et al. (2014) did not find
an effect on the Digit Span Backward test.25 If the cholinergic
activity was also enhanced in humans by WBV as we found in
mice, it could explain the improvement in the Stroop Color-
Word test. This test positively correlates with cholinergic
activity,49 although it should affect other tests as well. Possibly,
the used WBV protocol is not yet optimal to induce
Figure 5. Stroop Color-Word test scores for the experimental
(WBV) and the control (pWBV) group pre (black bars) and post
(white bars) intervention. Error bars are SEM; *P < .05. pWBV
denotes pseudo whole body vibration; SEM, standard error of the
mean; WBV, whole body vibration.
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improvements in the other tests. Anyway, we should interpret
this finding with caution given the small sample size of this
pilot study, the large age range and the high variability in
response as reflected in the standard deviations of the gain
scores. Future research with larger sample size should support
our findings. Also, research on potential neurobiological
mechanisms underlying the hypothesis that WBV affects inhi-
bition specifically is warranted. In addition, given the large
variability in response, future studies should investigate perso-
nalized settings, in which also the repeated exposure of short
bouts of WBV can be considered. Finally, more research is
necessary to examine the population specificity of WBV
effects. Especially people with cognitive impairments might
benefit from WBV. A recent study50 demonstrated that WBV
is feasible and safe in older people with dementia, although
they did not find evidence that WBV affected physical function
or quality of life in this specific population. However, whether
WBV affects cognitive function of people with dementia is still
unknown. Taken together, it is concluded that our 5-week
WBV intervention is a safe intervention to improve brain func-
tioning, although the subtle effects suggest that the protocol is
as yet suboptimal.
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